Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Parkinson's Disease

  Free Subscription


29.11.2021

1 BMC Neurol
1 Brain Res
1 J Biol Chem
2 J Neural Transm (Vienna)
1 J Neurochem
2 J Neurosci
1 Lancet Neurol
4 Mov Disord
1 Neurol Genet
1 PLoS Comput Biol
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    BMC Neurol

  1. HUTCHISON RM, Evans KC, Fox T, Yang M, et al
    Evaluating dopamine transporter imaging as an enrichment biomarker in a phase 2 Parkinson's disease trial.
    BMC Neurol. 2021;21:459.
    PubMed         Abstract available


    Brain Res

  2. ZHOU S, Zhang D, Guo J, Chen Z, et al
    Deficiency of NEAT1 prevented MPP(+)-induced inflammatory response, oxidative stress and apoptosis in dopaminergic SK-N-SH neuroblastoma cells via miR-1277-5p/ARHGAP26 axis.
    Brain Res. 2021;1750:147156.
    PubMed         Abstract available


    J Biol Chem

  3. GANDELMAN M, Dansithong W, Kales SC, Paul S, et al
    The AKT modulator A-443654 reduces alpha-synuclein expression and normalizes ER stress and autophagy.
    J Biol Chem. 2021;297:101191.
    PubMed         Abstract available


    J Neural Transm (Vienna)

  4. ALTMANN CF, Trubelja K, Emmans D, Jost WH, et al
    Time-course of decline in different cognitive domains in Parkinson's disease: a retrospective study.
    J Neural Transm (Vienna). 2021 Nov 24. pii: 10.1007/s00702-021-02441.
    PubMed         Abstract available

  5. DERKINDEREN P, Cossais F, de Guilhem de Lataillade A, Leclair-Visonneau L, et al
    Gastrointestinal mucosal biopsies in Parkinson's disease: beyond alpha-synuclein detection.
    J Neural Transm (Vienna). 2021 Nov 24. pii: 10.1007/s00702-021-02445.
    PubMed         Abstract available


    J Neurochem

  6. GUO YJ, Ayton S, Lei P
    Iron reduces the propagation of pathological alpha-synuclein: An Editorial Highlight for "Brain iron enrichment attenuates alpha-synuclein spreading after injection of preformed fibrils" on page 554.
    J Neurochem. 2021;159:414-416.
    PubMed         Abstract available


    J Neurosci

  7. SALAMONE PC, Legaz A, Sedeno L, Moguilner S, et al
    Interoception Primes Emotional Processing: Multimodal Evidence from Neurodegeneration.
    J Neurosci. 2021;41:4276-4292.
    PubMed         Abstract available

  8. HE S, Deli A, Fischer P, Wiest C, et al
    Gait-Phase Modulates Alpha and Beta Oscillations in the Pedunculopontine Nucleus.
    J Neurosci. 2021;41:8390-8402.
    PubMed         Abstract available


    Lancet Neurol

  9. MOK KY
    The East Asian Parkinson Disease Genomics Consortium.
    Lancet Neurol. 2021;20:982.
    PubMed        


    Mov Disord

  10. ERRO R, Mencacci NE, Bhatia KP
    The Emerging Role of Phosphodiesterases in Movement Disorders.
    Mov Disord. 2021;36:2225-2243.
    PubMed         Abstract available

  11. WERNER MH, Olanow CW
    Parkinson's Disease Modification through Abl Kinase Inhibition: An Opportunity.
    Mov Disord. 2021 Nov 23. doi: 10.1002/mds.28858.
    PubMed         Abstract available

  12. SCAMARCIA PG, Agosta F, Spinelli EG, Basaia S, et al
    Longitudinal White Matter Damage Evolution in Parkinson's Disease.
    Mov Disord. 2021 Nov 22. doi: 10.1002/mds.28864.
    PubMed         Abstract available

  13. SASIKUMAR S, Cohn M, Harmsen IE, Loh A, et al
    Single-Trajectory Multiple-Target Deep Brain Stimulation for Parkinsonian Mobility and Cognition.
    Mov Disord. 2021 Nov 22. doi: 10.1002/mds.28870.
    PubMed         Abstract available


    Neurol Genet

  14. BAVIERA-MUNOZ R, Martinez-Rubio D, Sastre-Bataller I, Campins-Romeu M, et al
    A 3.9-Mb Deletion on 2p11.2 Comprising the REEP1 Gene Causes Early-Onset Atypical Parkinsonism.
    Neurol Genet. 2021;7:e642.
    PubMed        


    PLoS Comput Biol

  15. WEERASINGHE G, Duchet B, Bick C, Bogacz R, et al
    Optimal closed-loop deep brain stimulation using multiple independently controlled contacts.
    PLoS Comput Biol. 2021;17:e1009281.
    PubMed         Abstract available


    PLoS One

  16. SHAMADYKOVA DV, Panteleev DY, Kust NN, Savchenko EA, et al
    Neuroinductive properties of mGDNF depend on the producer, E. Coli or human cells.
    PLoS One. 2021;16:e0258289.
    PubMed         Abstract available

  17. ELFARRASH S, Jensen NM, Ferreira N, Schmidt SI, et al
    Polo-like kinase 2 inhibition reduces serine-129 phosphorylation of physiological nuclear alpha-synuclein but not of the aggregated alpha-synuclein.
    PLoS One. 2021;16:e0252635.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: